A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 90, Issue 10, 1993, Pages 4345-4349

  Moody, T W ^a   Zia, F ^a   Draoui, M ^a   Brenneman, D E ^a   Fridkin, M ^a   Davidson, A ^a   Gozes, I ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

cAMP; vasoactive intestinal peptide receptors

Indexed keywords

CELL RECEPTOR; CYCLIC AMP; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VIPHYB;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 0027276302     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.90.10.4345     Document Type: Article

References (0)